Welgene Biotech Co.,Ltd. (6661.TWO)
TWD 23.6
(0.85%)
TWD 23.6
(0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -366 Thousand | 51.42 Million | 11.24 Million | 41.76 Million | 85.14 Million | 48.81 Million |
| Net Income | -3.03 Million | 13.55 Million | 16.59 Million | 37.13 Million | 39.84 Million | 37.13 Million |
| Depreciation & Amortization | 27.25 Million | 19.04 Million | 19.21 Million | 18.44 Million | 8.02 Million | 7.62 Million |
| Deferred income taxes | - | - | -10.42 Million | - | - | - |
| Stock-based compensation | - | - | 2000.00 | - | - | - |
| Change in working capital | -14.85 Million | 16.59 Million | -14.4 Million | -1.98 Million | 44.61 Million | 8.26 Million |
| Other non-cash items | -9.73 Million | 2.24 Million | 257 Thousand | -11.82 Million | -7.34 Million | -4.21 Million |
| Investing Cash Flow | 5.99 Million | -67.98 Million | -10.33 Million | -9.6 Million | -25.39 Million | -21.9 Million |
| Investments in PPE | -27.73 Million | -26.85 Million | -4.37 Million | -5.91 Million | -8.64 Million | -9.25 Million |
| Acquisitions | -12.8 Million | - | 236 Thousand | -10 Million | -9.7 Million | -10 Million |
| Investment purchases | -3.78 Million | -93.54 Million | -65.48 Million | 2.93 Million | -6.17 Million | -2 Million |
| Sales/Maturities of investments | 50.07 Million | 51.38 Million | 59.8 Million | 1 Million | 260 Thousand | 11 Thousand |
| Other Investing Activities | 245 Thousand | 1.02 Million | -526 Thousand | 2.37 Million | -1.14 Million | -660 Thousand |
| Financing Cash Flow | 23.9 Million | -24.61 Million | 38.52 Million | -43.11 Million | -29.17 Million | -25.16 Million |
| Debt repayment | -26.62 Million | -1.35 Million | -5.56 Million | -4 Million | -3.01 Million | -19.19 Million |
| Dividends payments | -4.22 Million | -11.28 Million | -25.67 Million | -27.76 Million | -26.13 Million | -5.96 Million |
| Common Stock Repurchased | - | - | -11.34 Million | - | - | - |
| Common Stock Issuance | 2.3 Million | - | 69.98 Million | - | - | - |
| Other Financing Activities | 1.51 Million | -11.97 Million | 11.12 Million | -11.35 Million | -21 Thousand | -7000.00 |
| Accounts receivables | 3.14 Million | 37.71 Million | -21.24 Million | 33.84 Million | 12.74 Million | -48.7 Million |
| Accounts payables | -1.88 Million | 6.46 Million | -2.91 Million | -4.73 Million | 4.66 Million | -541 Thousand |
| Inventory | -10.64 Million | -8.84 Million | -7.99 Million | 9.51 Million | 7.14 Million | 8.75 Million |
| Other working capital | -5.47 Million | -18.73 Million | 17.75 Million | -40.61 Million | 20.06 Million | -491 Thousand |
| Cash at beginning of period | 158.59 Million | 199.76 Million | 160.33 Million | 171.28 Million | 140.71 Million | 138.97 Million |
| Cash at end of period | 188.13 Million | 158.59 Million | 199.76 Million | 160.33 Million | 171.28 Million | 140.71 Million |
| Capital Expenditure | -27.73 Million | -26.85 Million | -4.37 Million | -5.91 Million | -8.64 Million | -9.25 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 29.53 Million | -41.17 Million | 39.43 Million | -10.95 Million | 30.57 Million | 1.74 Million |
| Free Cash Flow | -28.1 Million | 24.56 Million | 6.87 Million | 35.85 Million | 76.5 Million | 39.55 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -529 Thousand | -5.56 Million | -3.17 Million | -3.03 Million | -1.38 Million | 6.4 Million |
| Depreciation & Amortization | 7.27 Million | 7.26 Million | 7.33 Million | 27.25 Million | 6.87 Million | 7.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -18.75 Million | -8.5 Million | 13.57 Million | -14.85 Million | -5.26 Million | -23.92 Million |
| Other non-cash items | 35.08 Million | 736 Thousand | 287 Thousand | -9.73 Million | -2.72 Million | -5.84 Million |
| Investing Cash Flow | -214 Thousand | -829 Thousand | 45.55 Million | 5.99 Million | -15.12 Million | -19.15 Million |
| Investments in PPE | -94 Thousand | -1.46 Million | -3.58 Million | -27.73 Million | -15.89 Million | -2.2 Million |
| Acquisitions | - | - | - | -12.8 Million | -220 Thousand | -12.8 Million |
| Investment purchases | - | - | - | -3.78 Million | -3.78 Million | -3.78 Million |
| Sales/Maturities of investments | - | - | 50 Million | 50.07 Million | 4 Million | 70 Thousand |
| Other Investing Activities | -120 Thousand | 631 Thousand | -855 Thousand | 245 Thousand | 773 Thousand | -429 Thousand |
| Financing Cash Flow | 4.89 Million | -7.99 Million | 26.58 Million | 23.9 Million | -5.3 Million | -18.4 Million |
| Debt repayment | -8.46 Million | -3.75 Million | -20.28 Million | -26.62 Million | -5.08 Million | -4.79 Million |
| Dividends payments | - | - | - | -4.22 Million | - | -4.22 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 2.3 Million | 2.3 Million | - | - |
| Other Financing Activities | 11.22 Million | -661 Thousand | 6.3 Million | 1.51 Million | -220 Thousand | -9.38 Million |
| Accounts receivables | -7.38 Million | 3.27 Million | 3.82 Million | 3.14 Million | -2.41 Million | -12.74 Million |
| Accounts payables | 4.2 Million | -2.28 Million | 8.83 Million | -1.88 Million | -17.41 Million | 18.07 Million |
| Inventory | -16.57 Million | 6.03 Million | -9.31 Million | -10.64 Million | 11.4 Million | -14.03 Million |
| Other working capital | 994 Thousand | -15.53 Million | 10.22 Million | -5.47 Million | 3.14 Million | -15.22 Million |
| Cash at beginning of period | 175.21 Million | 188.13 Million | 97.95 Million | 158.59 Million | 120.88 Million | 174.66 Million |
| Cash at end of period | 168.67 Million | 174.51 Million | 188.13 Million | 188.13 Million | 97.95 Million | 120.88 Million |
| Capital Expenditure | -94 Thousand | -1.46 Million | -3.58 Million | -27.73 Million | -15.89 Million | -2.2 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.54 Million | -13.61 Million | 90.17 Million | 29.53 Million | -22.92 Million | -53.77 Million |
| Free Cash Flow | -11.31 Million | -6.25 Million | 14.43 Million | -28.1 Million | -18.39 Million | -18.42 Million |
1663
FONR
9988
ASMB
PBCO
7844